253 related articles for article (PubMed ID: 9689663)
1. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
Richard S; Beroud C; Joly D; Chretien Y; Benoit G
Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
[TBL] [Abstract][Full Text] [Related]
2. [Does hemangioblastoma exist outside von Hippel-Lindau disease?].
Richard S; Beigelman C; Gerber S; Van Effenterre R; Gaudric A; Sahel M; Binaghi M; De Kersaint-Gilly A; Houtteville JP; Brunon JP
Neurochirurgie; 1994; 40(3):145-54. PubMed ID: 7723921
[TBL] [Abstract][Full Text] [Related]
3. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
[TBL] [Abstract][Full Text] [Related]
4. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
5. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the VHL tumour suppressor gene in renal carcinoma.
Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
[TBL] [Abstract][Full Text] [Related]
7. Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease.
Huang JS; Huang CJ; Chen SK; Chien CC; Chen CW; Lin CM
Eur J Clin Invest; 2007 Jun; 37(6):492-500. PubMed ID: 17537157
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic studies of sporadic and familial renal cell carcinoma.
Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
[TBL] [Abstract][Full Text] [Related]
9. [Von Hippel-Lindau disease and molecular genetic diagnosis].
Jensen AM; Bisgaard ML
Ugeskr Laeger; 1999 Feb; 161(7):959-61. PubMed ID: 10051806
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
11. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
13. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
Pack SD; Zbar B; Pak E; Ault DO; Humphrey JS; Pham T; Hurley K; Weil RJ; Park WS; Kuzmin I; Stolle C; Glenn G; Liotta LA; Lerman MI; Klausner RD; Linehan WM; Zhuang Z
Cancer Res; 1999 Nov; 59(21):5560-4. PubMed ID: 10554035
[TBL] [Abstract][Full Text] [Related]
14. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.
Gnarra JR; Lerman MI; Zbar B; Linehan WM
Semin Oncol; 1995 Feb; 22(1):3-8. PubMed ID: 7855617
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications.
Walther MM; Lubensky IA; Venzon D; Zbar B; Linehan WM
J Urol; 1995 Dec; 154(6):2010-4; discussion 2014-5. PubMed ID: 7500446
[TBL] [Abstract][Full Text] [Related]
16. [Von Hippel-Lindau disease].
Los M; Links TP; Lenders JW; Voest EE
Ned Tijdschr Geneeskd; 2000 Mar; 144(11):497-501. PubMed ID: 10735133
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas.
Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G
J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207
[TBL] [Abstract][Full Text] [Related]
18. [Pheochromocytoma, first manifestation of Von Hippel-Lindau disease: a possibility to be considered].
Richard S; Resche F; Vermesse B; Fendler JP; Francillard M; Laroche F; Luton JP; Méry JP; Proye C; Redondo A
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1153-6. PubMed ID: 1482250
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of von Hippel-Lindau disease.
Nordstrom-O'Brien M; van der Luijt RB; van Rooijen E; van den Ouweland AM; Majoor-Krakauer DF; Lolkema MP; van Brussel A; Voest EE; Giles RH
Hum Mutat; 2010 May; 31(5):521-37. PubMed ID: 20151405
[TBL] [Abstract][Full Text] [Related]
20. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]